ARTICLE | Clinical News
Apogee Biotechnology, RedHill preclinical data
September 7, 2015 7:00 AM UTC
In a xenograft model of prostate cancer, oral ABC294640 significantly inhibited tumor growth. Data were published in Molecular Cancer Research. RedHill is evaluating the small molecule inhibitor of s...